VMLY&R and AstraZeneca Win Gold

PM360 magazine has announced the AstraZeneca / FluMist team at VMLY&R as a Gold Winner in the video category of the publication’s Pharma Choice Awards.

Since 2009, the PM360 Pharma Choice awards have recognized outstanding achievement and creativity in healthcare and life sciences marketing by allowing the industry as a whole to choose the winners. All submissions are placed online where anyone in the industry can vote for their favorites based on content, format, imagination, influence on the industry, impact on the audience, and overall quality. This year, more than 8,000 votes were cast to decide the winners.

“Creativity within the life sciences industry means something different. It means thinking within strict regulated lines. It means engaging with people who would much prefer to be healthy and not have to hear from you. It means everything you do matters, because people’s health—and sometimes even their lives—are at stake,” said Anna Stashower, CEO/Publisher/Editor-in-Chief, PM360. “It is all of those things that makes the creative achievements within our industry mean so much more—the very best campaigns ultimately help to improve people’s lives. This year’s Pharma Choice winners, which are voted on by an industry that knows those stakes all too well, represent the campaigns and initiatives from 2021 that excelled at overcoming all those challenges to create something that truly means something to the patients, caregivers, doctors, or other health stakeholders they were trying to reach.”

In total, 39 winners were named in 13 distinct categories: App, Consumer Website, DTC/DTP, Multichannel, Multicultural, Professional Print Campaign, Professional Website, Sales Aid, Self-promotion, Social Media, Unbranded, Variety, and Video. A Gold, Silver, and Bronze award is given to the entries that receive the top three most in each category.

The winning work is featured in the January/February 2022 issue of PM360. And can be viewed online at www.pm360online.com/2021-pm360-pharma-choice-award-winners.